nothing unusual with medicine approval process with FDA. sentiment changes but fundamentally speaking , it is all about right track.
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren approaching key milestones in Q4 2019
Ann: Neuren approaching key milestones in Q4 2019, page-32
-
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.31 |
Change
-0.960(4.51%) |
Mkt cap ! $2.595B |
Open | High | Low | Value | Volume |
$20.98 | $21.06 | $20.18 | $3.467M | 168.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 169 | $20.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.32 | 232 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 477 | 20.280 |
3 | 253 | 20.270 |
3 | 173 | 20.260 |
5 | 432 | 20.250 |
2 | 168 | 20.240 |
Price($) | Vol. | No. |
---|---|---|
20.300 | 648 | 6 |
20.310 | 50 | 1 |
20.320 | 175 | 3 |
20.330 | 158 | 2 |
20.340 | 182 | 2 |
Last trade - 14.01pm 01/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online